Stocks making the biggest moves midday: GameStop, Tesla, FedEx and more

Stocks making the biggest moves midday: GameStop, Tesla, FedEx and more


Shoppers wait for a GameStop store to open on at the Tysons Corner Center, in Tysons, Virginia, November 27, 2020.

Hannah McKay | Reuters

Check out the companies making headlines in midday trading Friday.

GameStop — Shares of the video game retailer gained about 2%, erasing big overnight losses, as investors looked past the company’s unexpected loss during the holiday quarter. GameStop said it’s launching a new marketplace for nonfungible tokens, or NFTs, by the end of the second quarter.

FedEx — FedEx shares fell 5% after the company missed earnings estimates for the quarter. The company beat on revenue but said worker shortages amid the omicron variant outbreak hurt its bottom line.

Tesla — Shares gained 2.9% after Morgan Stanley reiterated its overweight rating on Tesla. The call came after CEO Elon Musk tweeted that he was “Working on master plan part 3.” Morgan Stanley said it sees “Part 3 as mass industrialization, a network flywheel and ‘connecting the dots’ across adjacent TAMs.”

Moderna — Shares of Moderna rose 4.4% on news that it is seeking FDA approval for a second Covid-19 booster shot for adults 18 years or older. Pfizer and its partner BioNTech requested approval for a Covid-19 booster for those 65 and older this week.

Rent the Runway — Shares of the fashion rental company soared 30% after Jefferies initiated coverage of the company with a buy rating, noting the company’s high barrier to entry could help it drive as much as 50% top-line growth. Jefferies also initiated coverage of the RealReal, Farfetch and ThredUp with buy ratings. The stocks rose 9%, 5% and 4%, respectively.

Joann — The craft retailer’s stock plummeted 10.7% after the company reported disappointing quarterly sales for the previous quarter. Joann also saw a $60 million increase in ocean freight costs last year — one of many supply chain disruptions. Piper Sandler downgraded the retailer to neutral from overweight.

Wingstop — Shares of the chicken wings restaurant franchise fell nearly 5% in midday trading after Piper Sandler downgraded the stock to underweight from overweight. The firm expects the stock to experience resistance in the near term.

MongoDB — Shares of the tech company rose nearly 5% after an upgrade to buy from UBS. The investment firm said in a note to clients that the company is gaining more traction with customers.

Garmin — The consumer electronics stock gained 2.7% on the heels of an upgrade to buy from Bank of America. The recent pullback in the stock makes Garmin a buy the dip candidate considering its strong fundamentals, Bank of America said in a note to clients.

U.S. Steel — Shares of U.S. Steel fell 6% after issuing weaker-than-expected guidance for the quarter, The company cited increasing raw materials costs as one of the contributors.

— CNBC’s Yun Li, Jesse Pound, Hannah Miao and Maggie Fitzgerald contributed reporting



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More